Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "DGME"

25 News Found

Yashoda Medicity gets DGME approval for brain stem death certification committee
Hospitals | June 09, 2026

Yashoda Medicity gets DGME approval for brain stem death certification committee

The newly constituted committee will facilitate timely brain stem death certification, supporting transparent organ donation processes and expanding opportunities for patients awaiting transplants


RedHill secures final $10.5M court judgment for enforcement
Biopharma | November 06, 2025

RedHill secures final $10.5M court judgment for enforcement

RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment


Supreme Court declares right to trauma care part of Article 21 in landmark judgement
Healthcare | May 29, 2026

Supreme Court declares right to trauma care part of Article 21 in landmark judgement

The ruling comes against the backdrop of a mounting trauma burden in India, where nearly 4.67 lakh accidental deaths occur annually


Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi
Opinion | May 22, 2026

Multimodal AI emerges as next leap in predictive healthcare: Ashwattha Sahasrabuddhe, Principal Architect and Technology & Practice Head – Healthcare Business, Tata Elxsi

Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond


Women’s hospital opens in Delhi with $5 million backing
Hospitals | May 18, 2026

Women’s hospital opens in Delhi with $5 million backing

30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage


Zydus Lifesciences subsidiary faces Rs 9 million GST demand notice
Biopharma | May 05, 2026

Zydus Lifesciences subsidiary faces Rs 9 million GST demand notice

Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims


FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis
News | May 02, 2026

FDA grants breakthrough status to Laguna's mRNA blood test for schizophrenia diagnosis

The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay


The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings
interviews | April 28, 2026

The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings

With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints


CDSCO rolls out prior intimation system to fast-track drug testing and R&D
Drug Approval | April 21, 2026

CDSCO rolls out prior intimation system to fast-track drug testing and R&D

Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development


Pinky Promise opens first physical clinic in Mumbai, expands women’s hybrid healthcare model
Healthcare | April 15, 2026

Pinky Promise opens first physical clinic in Mumbai, expands women’s hybrid healthcare model

AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India